AIG
CRDF icon

American International Group’s Cardiff Oncology CRDF Stock Holding History

American International Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,907
Closed -$47K – 3125
2022
Q1 		$47K Sell
18,907
-1,332
-7% -$4.71K ﹤0.01% 2864
2021
Q4 		$122K Sell
20,239
-605
-3% -$3.61K ﹤0.01% 2630
2021
Q3 		$139K Buy
20,844
+583
+3% +$3.66K ﹤0.01% 2640
2021
Q2 		$135K Buy
+20,261
New +$172K ﹤0.01% 2747
2017
Q2 		– Sell
-241
Closed -$20K – 3085
2017
Q1 		$20K Buy
241
+16
+7% +$2.17K ﹤0.01% 2954
2016
Q4 		$34K Sell
225
-1
-0.4% -$234 ﹤0.01% 2920
2016
Q3 		$72.9K Buy
226
+1
+0.4% +$365 ﹤0.01% 2783
2016
Q2 		$73.5K Sell
225
-2,347
-91% -$808K ﹤0.01% 2806
2016
Q1 		$861K Buy
2,572
+1,305
+103% +$444K ﹤0.01% 1591
2015
Q4 		$492K Buy
1,267
+112
+10% +$43.9K ﹤0.01% 2048
2015
Q3 		$474K Buy
1,155
+956
+480% +$500K ﹤0.01% 2070
2015
Q2 		$145K Buy
+199
New +$141K ﹤0.01% 3326
2014
Q2 		– Sell
-49
Closed -$20.1K – 4970
2014
Q1 		$20.1K Hold
49
– – ﹤0.01% 4183
2013
Q4 		$20.1K Hold
49
– – ﹤0.01% 4125
2013
Q3 		$25.1K Buy
+49
New +$27.9K ﹤0.01% 3999

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

American International Group's CRDF Position: Q2 2022 in Review

American International Group sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 18,907 shares — an estimated $47K sold.

American International Group first reported a position in CRDF in Q3 2013 and held it in 15 quarters. The position peaked at $861K in Q1 2016. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • American International Group reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 18,907 Cardiff Oncology shares in Q2 2022, an estimated $47K.
  • American International Group first reported a position in Cardiff Oncology in Q3 2013 and held it in 15 quarters.
  • American International Group's Cardiff Oncology position peaked at $861K in Q1 2016.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.